Target Price | $179.52 |
Price | $157.32 |
Potential | 14.11% |
Number of Estimates | 29 |
29 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $179.52. This is 14.11% higher than the current stock price. The highest price target is $195.30 24.14% , the lowest is $145.65 7.42% . | |
A rating was issued by 35 analysts: 23 Analysts recommend Procter & Gamble to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 14.11% . Most analysts recommend the Procter & Gamble stock at Purchase. |
28 Analysts have issued a sales forecast Procter & Gamble 2026 . The average Procter & Gamble sales estimate is $89.6b . This is 6.30% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $92.1b 9.24% , the lowest is $83.7b 0.71% .
This results in the following potential growth metrics:
2025 | $84.3b | 0.29% |
---|---|---|
2026 | $89.6b | 6.30% |
2027 | $92.3b | 3.07% |
2028 | $95.7b | 3.65% |
2029 | $98.4b | 2.85% |
2030 | $102b | 3.86% |
2031 | $107b | 4.50% |
2032 | $111b | 3.70% |
24 Analysts have issued an Procter & Gamble EBITDA forecast 2026. The average Procter & Gamble EBITDA estimate is $25.0b . This is 5.97% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $26.5b 11.99% , the lowest is $23.4b 1.09% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $23.6b | 1.87% |
---|---|---|
2026 | $25.0b | 5.97% |
2027 | $26.4b | 5.30% |
2028 | $27.4b | 4.12% |
2029 | $28.1b | 2.23% |
2030 | $29.1b | 3.81% |
2031 | $29.9b | 2.55% |
2032 | $31.0b | 3.70% |
2025 | 28.02% | 1.58% |
---|---|---|
2026 | 27.94% | 0.30% |
2027 | 28.54% | 2.15% |
2028 | 28.67% | 0.46% |
2029 | 28.50% | 0.59% |
2030 | 28.48% | 0.07% |
2031 | 27.95% | 1.86% |
2032 | 27.95% | 0.00% |
28 Procter & Gamble Analysts have issued a net profit forecast 2026. The average Procter & Gamble net profit estimate is $16.9b . This is 7.65% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $17.5b 11.31% , the lowest is $15.9b 1.10% .
This results in the following potential growth metrics and future Net Margins:
2025 | $15.7b | 7.45% |
---|---|---|
2026 | $16.9b | 7.64% |
2027 | $18.0b | 6.38% |
2028 | $19.0b | 5.62% |
2029 | $19.4b | 2.11% |
2030 | $20.4b | 5.24% |
2031 | $21.7b | 6.52% |
2032 | $22.9b | 5.67% |
2025 | 18.61% | 7.14% |
---|---|---|
2026 | 18.84% | 1.26% |
2027 | 19.45% | 3.24% |
2028 | 19.82% | 1.90% |
2029 | 19.67% | 0.76% |
2030 | 19.93% | 1.32% |
2031 | 20.32% | 1.96% |
2032 | 20.71% | 1.92% |
28 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $7.20 . This is 12.32% higher than earnings per share in the financial year 2025. The highest EPS forecast is $7.44 16.07% , the lowest is $6.76 5.46% .
This results in the following potential growth metrics and future valuations:
2025 | $6.38 | 8.14% |
---|---|---|
2026 | $7.20 | 12.85% |
2027 | $7.66 | 6.39% |
2028 | $8.09 | 5.61% |
2029 | $8.26 | 2.10% |
2030 | $8.69 | 5.21% |
2031 | $9.26 | 6.56% |
2032 | $9.79 | 5.72% |
Current | 24.54 | 16.82% |
---|---|---|
2026 | 21.85 | 10.97% |
2027 | 20.54 | 6.00% |
2028 | 19.45 | 5.31% |
2029 | 19.04 | 2.11% |
2030 | 18.10 | 4.94% |
2031 | 16.99 | 6.13% |
2032 | 16.08 | 5.36% |
Based on analysts' sales estimates for 2026, the Procter & Gamble stock is valued at an EV/Sales of 4.39 and an P/S ratio of 4.11 .
This results in the following potential growth metrics and future valuations:
Current | 4.66 | 9.34% |
---|---|---|
2026 | 4.39 | 5.83% |
2027 | 4.26 | 2.98% |
2028 | 4.11 | 3.52% |
2029 | 3.99 | 2.77% |
2030 | 3.85 | 3.72% |
2031 | 3.68 | 4.31% |
2032 | 3.55 | 3.57% |
Current | 4.37 | 10.24% |
---|---|---|
2026 | 4.11 | 5.93% |
2027 | 3.99 | 2.98% |
2028 | 3.85 | 3.52% |
2029 | 3.74 | 2.77% |
2030 | 3.60 | 3.72% |
2031 | 3.45 | 4.30% |
2032 | 3.32 | 3.57% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
BNP Paribas |
Outperform
➜
Outperform
|
Unchanged | Aug 15 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 31 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2025 |
JP Morgan |
Overweight
➜
Neutral
|
Downgrade | Jul 25 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Jul 17 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 15 2025 |
Evercore ISI Group |
Outperform
➜
In-Line
|
Downgrade | Jul 14 2025 |
Analyst Rating | Date |
---|---|
Unchanged
BNP Paribas:
Outperform
➜
Outperform
|
Aug 15 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 31 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jul 30 2025 |
Downgrade
JP Morgan:
Overweight
➜
Neutral
|
Jul 25 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Jul 17 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 15 2025 |
Downgrade
Evercore ISI Group:
Outperform
➜
In-Line
|
Jul 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.